Ingredient or product comparison
GHK-Cu Help Skin Elasticity: Comparison to Other Collagen-Stimulating Compounds
GHK-Cu (200–300 mcg topical) Activates lysyl oxidase via copper delivery; upregulates COL1A1 and ELN transcription; inhibits MMPs 14–22% improvement in cutometry elasticity parameters at 8–12 weeks (multiple RCTs) 8–12 weeks Excellent. Minimal irritation, no p
This source-based comparison does not add ratings or recommend a winner.
- GHK-Cu (200–300 mcg topical)
- Activates lysyl oxidase via copper delivery; upregulates COL1A1 and ELN transcription; inhibits MMPs
- 14–22% improvement in cutometry elasticity parameters at 8–12 weeks (multiple RCTs)
- 8–12 weeks
- Excellent. Minimal irritation, no photosensitivity
- Best choice for individuals who cannot tolerate retinoids or prefer a single-pathway collagen stimulus without inflammation risk
- Tretinoin (0.05% topical)
- Increases fibroblast activity via retinoic acid receptor activation; stimulates collagen synthesis; normalizes keratinization
- 18–25% improvement in dermal density and elasticity at 6–12 months (multiple long-term studies)
- 12–24 weeks (after retinization period)
- Moderate. Peeling, irritation, photosensitivity common during first 8 weeks
- Gold standard for photoaging reversal but requires tolerance-building period and strict sun protection
- Ascorbic Acid (L-Ascorbic Acid, 15–20% topical)
- Cofactor for prolyl and lysyl hydroxylase (collagen synthesis enzymes); antioxidant reduces MMP upregulation
- 10–15% improvement in skin firmness and elasticity at 12 weeks (limited RCT data)
- 8–16 weeks
- Good. Oxidation and pH instability cause formulation challenges; some irritation at higher concentrations
- Effective but highly formulation-dependent. Most commercial vitamin C serums oxidize before achieving clinical benefit
- Matrixyl (Palmitoyl Pentapeptide-4)
- Stimulates TGF-β signaling to increase collagen I, III, and fibronectin production
- 6–10% improvement in elasticity (manufacturer-sponsored studies; limited independent replication)
- Excellent. Well-tolerated across all skin types
- Weaker efficacy signal than GHK-Cu in head-to-head comparisons; often combined with other actives rather than used as monotherapy
- Copper Peptides (Generic, Non-GHK)
- Variable. Depends on specific peptide sequence and copper binding affinity
- Insufficient clinical data. Most studies are in vitro or manufacturer-funded without peer review
- Unknown
- Variable. Depends on formulation stability and copper concentration
- 'Copper peptide' is not a single entity. GHK-Cu is one specific tripeptide with robust data; other sequences may or may not have equivalent activity